Aspen Pharmacare Asset Disposals: Future Opportunities

Learn about potential Aspen Pharmacare asset disposals aimed at optimising the company's global operations for greater profitability.
Lilly Hits $1 Trillion Valuation with Weight-Loss Success
Eli Lilly hits $1 trillion valuation, marking a historic milestone in the pharmaceutical industry with successful weight-loss drugs.
Life Healthcare Share Price Stumbles Following R2.9bn Liability Adjustment
Life Healthcare share price falls 9% due to R2.9bn adjustment linked to the Piramal liability affecting investor sentiment.
AfroCentric’s JSE Collapse Fuels a New Healthcare Empire
Explore how Sanlam's strategic patience with AfroCentric transforms market neglect into a promising opportunity in healthcare.
Aspen Shares Nosedive 15% on JSE After Shock Profit Warning
Aspen Pharmacare shares see a sharp decline on the JSE following an alarming profit warning. What does it mean for investors?